HyaRegen® Gel

Prevention of Adhesion

• Meticulous and careful surgical technique
• Prophylactic application of adhesion barrier

 ESGE Consensus guideline: Using adhesion reduction agents are an important part of adhesion reduction strategy; achieving full prevention de novo and reformed adhesions (De Wilde RL et al: Arch Gynecol Obstet. 2014; 290:581)

 Patient Benefits

• Reduced adhesions
• Enhanced pregnancy rate
• Limited bowel obstruction
• Improved quality of life
• Prevented re-admission
  

Unique features and functions

• Easy to use via endoscopy or open surgery
• Absorbable up to 14 days to provide complete coverage during the critical period of tissue repair
• Preventing adhesion in surgical intervention area and remote locations in entire abdominopelvic cavity
• Proven efficacious and safety from randomised clinical trial
  

HyaRegen Gel: unique material features

• Adequate viscosity and hydrophilic property: creation of moist environment facilitating scar free tissue regeneration
• Controlled degradation profile: physical barrier during the tissue healing critical period to prevent adhesion and scar formation
• Terminal sterilisation: maximized safety after application
• Degradable and completely bioresorbable: avoid secondary damage to the regenerated tissue
• Easy to use: no mixing required, flexible delivery cannula to facilitate application and to reach the desired location
• Non-animal-sourced hyaluronic acid raw material used for production: avoid potential reactions to xenogeneic proteins
• Optimized and controlled degradation of the Gel ensures complete coverage and protection to the organs

HyaRegen Gel degrades in abdominopelvic cavity for up to 14 days

• Covers traumatised organ surfaces during the critical period of tissue repair processes
• Provides effective barrier to separate the organs